Spark Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Spark Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-25,100	Closed	-$495K	–	588
2019 Q4	$495K	Buy	+25,100	New	+$401K	0.06%	349
2019 Q1	–	Sell	-44,300	Closed	-$489K	–	762
2018 Q4	$489K	Buy	+44,300	New	+$617K	0.03%	407
2016 Q4	–	Sell	-50,200	Closed	-$586K	–	939
2016 Q3	$586K	Buy	+50,200	New	+$590K	0.05%	455
2016 Q2	–	Sell	-36,600	Closed	-$338K	–	886
2016 Q1	$338K	Sell	36,600 -43,200	-54%	-$465K	0.03%	528
2015 Q4	$1.18M	Hold	79,800	–	–	0.15%	201
2015 Q3	$1.31M	Buy	+79,800	New	+$1.63M	0.17%	197
2014 Q2	–	Sell	-84,500	Closed	-$983K	–	781
2014 Q1	$983K	Buy	84,500 +32,200	+62%	+$545K	0.15%	220
2013 Q4	$924K	Buy	+52,300	New	+$879K	0.16%	213

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Spark Investment Management's MNTA Position: Q1 2020 in Review

Spark Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2020, closing a stake of 25,100 shares — an estimated $495K sold.

Spark Investment Management first reported a position in MNTA in Q4 2013 and held it in 8 quarters. The position peaked at $1.31M in Q3 2015. 199 funds tracked by Wall St. Rank hold MNTA as of Q1 2020.

Spark Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Spark Investment Management sold 25,100 Momenta Pharmaceuticals, Inc. shares in Q1 2020, an estimated $495K.
Spark Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 8 quarters.
Spark Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $1.31M in Q3 2015.
199 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2020.

Based on Spark Investment Management's 13F filing for Q1 2020, filed 12 May 2020.